Investors Appear Satisfied With Camurus AB (publ)'s (STO:CAMX) Prospects
Apr 19
Swedish (OMX) Pharma Industry Analysis
UpdatedApr 22, 2024
DataAggregated Company Financials
Companies34
- 7D-5.7%
- 3M-6.3%
- 1Y58.1%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 3.6%, driven by Swedencare declining 8.3%. In the past year, the industry has gained 65%. As for the next few years, earnings are expected to grow by 49% per annum.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 23 Apr 2024 | kr48.1b | kr6.2b | -kr1,040,638,863.10 | 76.1x | -46.2x | 7.7x |
| Thu, 21 Mar 2024 | kr50.7b | kr6.2b | -kr1,038,080,642.91 | 76x | -48.9x | 8.1x |
| Sat, 17 Feb 2024 | kr47.2b | kr6.1b | -kr931,676,075.29 | 58.7x | -50.6x | 7.7x |
| Mon, 15 Jan 2024 | kr73.1b | kr9.5b | -kr1,182,119,507.00 | 71.1x | -61.9x | 7.7x |
| Wed, 13 Dec 2023 | kr63.9b | kr9.4b | -kr1,184,548,480.00 | 58.4x | -54x | 6.8x |
| Fri, 10 Nov 2023 | kr56.7b | kr9.3b | -kr1,283,149,467.00 | 90x | -44.2x | 6.1x |
| Sun, 08 Oct 2023 | kr51.2b | kr9.2b | -kr1,180,572,714.00 | 116.3x | -43.4x | 5.6x |
| Tue, 05 Sep 2023 | kr51.1b | kr9.2b | -kr1,177,918,104.00 | 139.4x | -43.4x | 5.6x |
| Thu, 03 Aug 2023 | kr51.2b | kr8.9b | -kr1,414,189,135.00 | 87.5x | -36.2x | 5.7x |
| Sat, 01 Jul 2023 | kr47.4b | kr8.4b | -kr1,692,681,920.00 | 72.9x | -28x | 5.7x |
| Mon, 29 May 2023 | kr49.5b | kr8.4b | -kr1,592,308,240.00 | 76.5x | -31.1x | 5.9x |
| Wed, 26 Apr 2023 | kr45.9b | kr8.0b | -kr1,794,932,752.00 | 103.8x | -25.6x | 5.7x |
| Fri, 24 Mar 2023 | kr44.7b | kr8.0b | -kr1,793,530,171.00 | 83.6x | -24.9x | 5.6x |
| Sun, 19 Feb 2023 | kr44.2b | kr7.3b | -kr1,980,325,844.00 | 286.1x | -22.3x | 6x |
| Tue, 17 Jan 2023 | kr49.9b | kr7.3b | -kr1,913,031,833.00 | 291.7x | -26.1x | 6.8x |
| Thu, 15 Dec 2022 | kr50.2b | kr7.3b | -kr1,875,738,892.00 | 296x | -26.7x | 6.9x |
| Sat, 12 Nov 2022 | kr49.2b | kr6.8b | -kr1,877,316,291.00 | 57x | -26.2x | 7.2x |
| Mon, 10 Oct 2022 | kr49.3b | kr7.0b | -kr1,739,746,392.00 | 48.2x | -28.3x | 7.1x |
| Wed, 07 Sep 2022 | kr52.0b | kr7.0b | -kr1,737,280,063.00 | 57.2x | -29.9x | 7.5x |
| Fri, 05 Aug 2022 | kr54.2b | kr6.9b | -kr1,535,082,724.00 | 42.3x | -35.3x | 7.9x |
| Sun, 03 Jul 2022 | kr53.4b | kr5.9b | -kr1,509,116,648.00 | 42.3x | -35.4x | 9x |
| Tue, 31 May 2022 | kr54.3b | kr5.9b | -kr1,515,935,037.00 | 47.3x | -35.8x | 9.2x |
| Thu, 28 Apr 2022 | kr55.9b | kr5.5b | -kr1,335,933,728.00 | 37.8x | -41.8x | 10.1x |
| Sat, 26 Mar 2022 | kr52.6b | kr5.4b | -kr1,361,173,542.00 | 40.6x | -38.6x | 9.7x |
| Mon, 21 Feb 2022 | kr49.0b | kr5.3b | -kr1,062,074,181.00 | 79.1x | -46.1x | 9.2x |
| Wed, 19 Jan 2022 | kr49.2b | kr5.5b | -kr1,100,420,204.00 | 114.5x | -44.7x | 9x |
| Fri, 17 Dec 2021 | kr53.1b | kr5.5b | -kr1,096,565,796.00 | 117.3x | -48.4x | 9.7x |
| Sun, 14 Nov 2021 | kr58.2b | kr5.2b | -kr1,367,928,343.00 | 91x | -42.5x | 11.1x |
| Tue, 12 Oct 2021 | kr51.2b | kr4.8b | -kr1,582,258,477.00 | 141.9x | -32.4x | 10.7x |
| Thu, 09 Sep 2021 | kr58.2b | kr4.8b | -kr1,560,489,765.26 | 160.7x | -37.3x | 12.2x |
| Sat, 07 Aug 2021 | kr54.2b | kr4.8b | -kr1,412,039,942.26 | 162.3x | -38.4x | 11.3x |
| Fri, 30 Apr 2021 | kr53.9b | kr4.6b | -kr1,469,283,209.50 | 180.2x | -36.7x | 11.8x |
Price to Earnings Ratio
-36.7x
Current Industry PE
- Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 8.2x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 11% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Swedish Pharma compare with similar industries?
| SE Market | -1.61% | |
| Healthcare | -2.48% | |
| Pharma | -5.68% | |
| Pharma | -5.68% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IBT B Infant Bacterial Therapeutics | kr87.20 | 4.3% +kr48.5m | 84.7% | PS15255.9x | |
| CSMED CS Medica | kr.6.79 | 14.0% +kr.10.3m | -33.7% | PS78.4x | |
| PILA Pila Pharma | kr2.39 | 26.8% +kr12.0m | -17.0% | PS38.9x | |
| INDEX InDex Pharmaceuticals Holding | kr0.35 | 6.7% +kr11.7m | -11.9% | PS1.9x | |
| EEVIA Eevia Health Oyj | kr1.79 | 20.9% +kr11.1m | -23.5% | PS1.1x |
